Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Aptivus (tipranavir) is in a class of antiviral medication called protease inhibitors. This group of HIV medicines works by preventing HIV cells from multiplying in the body. Aptivus was approved by the FDA in 2005, and approved for pediatric use in 2008. Although Aptivus has been proved effective, it is theorized that its side effects may be more dangerous than alternative antiretrovirals.
Aptivus is manufactured by Boehringer Ingelheim and received a black box warning for the possibility of severe liver problems—especially in people who already had liver disease. It received another black box warning in 2006 warning of brain bleeding in patients taking the drug. Boehringer Ingelheim stated that it had knowledge of four cases of brain bleeding during clinical trials, and sent letters to physicians informing them about the case. Many of the patients who presented the side effect also had other conditions such as; lesions in the central nervous system, head trauma, recent brain surgery, and problems with blood clotting, high blood pressure and alcohol abuse.
Along with reports of hemorrhaging in the brain, Aptivus was linked to diabetes mellitus, hepatitis and increase in cholesterol.
Side effects may include:
Serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.